Citigroup’s Sanara MedTech SMTI Stock Holding History
Bought
Maintained
Sold
Other funds holding SMTI
VCM
SWM
Citigroup's SMTI Position: Q1 2026 in Review
Citigroup increased its Sanara MedTech (SMTI) stake by 41% in Q1 2026, buying an estimated $3.48K and bringing the position to 581 shares worth $9.98K. The position accounts for ﹤0.01% of the portfolio, ranked #5037.
Citigroup first reported a position in SMTI in Q4 2020 and has held it in 17 quarters since. The position peaked at $421K in Q4 2022. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.
- Citigroup held 581 shares of Sanara MedTech worth $9.98K as of Q1 2026.
- Citigroup bought 169 Sanara MedTech shares in Q1 2026, an estimated $3.48K.
- Sanara MedTech made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5037 holding.
- Citigroup first reported a position in Sanara MedTech in Q4 2020 and has held it in 17 quarters since.
- Citigroup's Sanara MedTech position peaked at $421K in Q4 2022.
- 65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.